Skip to main content

Advertisement

SpringerLink
Log in

Palliative Biliary Drainage Has No Effect on Survival in Pancreatic Cancer: Medical Oncology Perspective

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

Removal of obstructive jaundice in metastatic pancreatic cancer is an important part of palliative therapy. However, it is not known whether invasive procedures reduce cancer-related mortality. In this study, the effect of palliative biliary drainage on survival outcomes in pancreatic cancer patients was evaluated.

Methods

Patients diagnosed with pancreatic cancer and undergoing biliary drainage in two different centers between 2010 and 2019 were evaluated retrospectively.

Results

Biliary drainage was applied to 73 patients, constituting 20.6% of 355 patients included in the study. The median progression-free survival (PFS) of patients with biliary stent was 5 months, while the median PFS of patients without stenting was 5.5 months and the median overall survival (OS) was 11.1 and 11.5 months, respectively (p: 0.424, p: 0.802).

Conclusions

A positive effect of palliative biliary drainage on median PFS and OS could not be demonstrated in our study group. In pancreatic cancer, predictive markers are needed to select patients who can derive a survival benefit from biliary drainage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Khalaf N, El-Serag HB, Abrams HR, Thrift AP. Burden of pancreatic cancer: from epidemiology to practice. Clin Gastroenterol Hepatol [Internet]. 2021;19(5):876–84. Available from: https://doi.org/10.1016/j.cgh.2020.02.054

  2. Gupta R, Amanam I, Chung V. Current and future therapies for advanced pancreatic cancer. J Surg Oncol. 2017;116(1):25–34.

    Article  Google Scholar 

  3. Toki MI, Syrigos KN, Saif MW asi. The role of biliary drainage in patients with pancreatic adenocarcinoma. JOP. 2014;15(2):128–31.

  4. Perone JA, Riall TS, Olino K. Palliative care for pancreatic and periampullary cancer. Surg Clin North Am [Internet]. 2016;96(6):1415–30. Available from: https://doi.org/10.1016/j.suc.2016.07.012

  5. Boulay BR, Parepally M. Managing malignant biliary obstruction in pancreas cancer: Choosing the appropriate strategy. World J Gastroenterol. 2014;20(28):9345–53.

    PubMed  PubMed Central  Google Scholar 

  6. Moss AC, Morris E, Leyden J, MacMathuna P. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev. 2007;33(2):213–21.

    Article  Google Scholar 

  7. Pavlidis ET, Pavlidis TE. Pathophysiological consequences of obstructive jaundice and perioperative management. Hepatobiliary Pancreat Dis Int [Internet]. 2018;17(1):17–21. Available from: https://doi.org/10.1016/j.hbpd.2018.01.008

  8. Neal CP, Thomasset SC, Bools D, Sutton CD, Garcea G, Mann CD, et al. Combined percutaneousendoscopic stenting of malignant biliary obstruction: Results from 106 consecutive procedures and identification of factors associated with adverse outcome. Surg Endosc. 2010;24(2):423–31.

    Article  CAS  Google Scholar 

  9. Payne M, Burmeister EA, Waterhouse M, Jordan SJ, O’Connell DL, Merrett ND, et al. Biliary stenting in patients with pancreatic cancer: results from a population-based cohort study. Pancreas. 2018;47(1):80–6.

    Article  Google Scholar 

  10. Rees J, Mytton J, Evison F, Mangat KS, Patel P, Trudgill N. The outcomes of biliary drainage by percutaneous transhepatic cholangiography for the palliation of malignant biliary obstruction in England between 2001 and 2014: a retrospective cohort study. BMJ Open. 2020;10(1).

  11. Zhang DX, Di DY, Yuan SX, Tao L. Prognostic factors in patients with pancreatic cancer. Exp Ther Med. 2012;3(3):423–32.

    Article  Google Scholar 

  12. Sezgin C, Karabulut B, Uslu R, Sanli UA, Goksel G, Yuzer Y, et al. Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors. Scand J Gastroenterol. 2005;40(12):1486–92.

    Article  CAS  Google Scholar 

  13. Tas F, Sen F, Odabas H, Kilic L, Keskin S, Yildiz I. Performance status of patients is the major prognostic factor at all stages of pancreatic cancer. Int J Clin Oncol. 2013;18(5):839–46.

    Article  CAS  Google Scholar 

  14. Zhang GY, Li WT, Peng WJ, Li GD, He XH, Xu LC. Clinical outcomes and prediction of survival following percutaneous biliary drainage for malignant obstructive jaundice. Oncol Lett. 2014;7(4):1185–90.

    Article  Google Scholar 

  15. Wang L, Yu WF. Obstructive jaundice and perioperative management. Acta Anaesthesiol Taiwanica [Internet]. 2014;52(1):22–9. Available from: https://doi.org/10.1016/j.aat.2014.03.002

  16. Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc. 2002;56(6):835–41.

    Article  Google Scholar 

  17. Agalianos C, Paraskeva K, Gouvas N, Davides D, Dervenis C. Impact of biliary stenting on surgical outcome in patients undergoing pancreatectomy. A retrospective study in a single institution. Langenbeck’s Arch Surg. 2016;401(1):55–61.

  18. Viesca MFY, Arvanitakis M. Early diagnosis and management of malignant distal biliary obstruction: a review on current recommendations and guidelines. Clin Exp Gastroenterol. 2019;12:415–32.

    Article  Google Scholar 

  19. Meller MT, Arts GRJ, Dean JR. Outcomes in percutaneous stenting of non-hepato-biliary/pancreatic malignant jaundice. Eur J Cancer Care (Engl). 2010;19(5):664–8.

    Article  CAS  Google Scholar 

  20. Afshar M, Khanom K, Ting Ma Y, Punia P. Biliary stenting in advanced malignancy: an analysis of predictive factors for survival. Cancer Manag Res. 2014;6:475–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Faculty, Division of Medical Oncology, Department of Internal Medicine, Manisa Celal Bayar University, Manisa, Turkey

    Atike Pınar Erdoğan, Ferhat Ekinci & Gamze Göksel

  2. Tatvan State Hospital Medical Oncology Clinic, Bitlis, Turkey

    Serkan Yıldırım

  3. İzmir Kent Hospital Medical Oncology Clinic, İzmir, Turkey

    Ahmet Özveren

Authors
  1. Atike Pınar Erdoğan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ferhat Ekinci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Serkan Yıldırım
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahmet Özveren
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gamze Göksel
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

APE, FE, and GG conceived and designed research. APE, FE, SY, and AÖ collected and processed data. AÖ and SY analyzed and interpreted data. APE and FE wrote the manuscript. GG supervised and made critical review. All authors read and approved the manuscript.

Corresponding author

Correspondence to Atike Pınar Erdoğan.

Ethics declarations

Ethics Approval

Our study was conducted according to the criteria set by the Declaration of Helsinki, and Manisa Celal Bayar University Faculty of Medicine Ethics Committee approved the study (approval no: 22.03.2021, date: 142).

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erdoğan, A.P., Ekinci, F., Yıldırım, S. et al. Palliative Biliary Drainage Has No Effect on Survival in Pancreatic Cancer: Medical Oncology Perspective. J Gastrointest Canc 53, 52–56 (2022). https://doi.org/10.1007/s12029-021-00754-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-021-00754-3

Keywords

Search

Navigation